These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 15233567)

  • 41. [What do health professionals ask RELIS Vest service and how satisfied are they with the answers?].
    Schjøtt J; Pomp E; Gedde-Dahl A; Hundal O; Dybendal T; Opedal K
    Tidsskr Nor Laegeforen; 2000 Jan; 120(2):204-7. PubMed ID: 10851917
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Classification of drug-related problems].
    Ruths S; Viktil KK; Blix HS
    Tidsskr Nor Laegeforen; 2007 Nov; 127(23):3073-6. PubMed ID: 18049498
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Black box warning contraindicated comedications: concordance among three major drug interaction screening programs.
    Wang LM; Wong M; Lightwood JM; Cheng CM
    Ann Pharmacother; 2010 Jan; 44(1):28-34. PubMed ID: 20040698
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Drug interaction microcomputer software evaluation: Drug Master 89.
    Poirier TI; Giudici RA
    Hosp Pharm; 1989 Dec; 24(12):1003-6. PubMed ID: 10296552
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Mini-Sentinel and regulatory science--big data rendered fit and functional.
    Psaty BM; Breckenridge AM
    N Engl J Med; 2014 Jun; 370(23):2165-7. PubMed ID: 24897081
    [No Abstract]   [Full Text] [Related]  

  • 46. An algorithm to derive a numerical daily dose from unstructured text dosage instructions.
    Shah AD; Martinez C
    Pharmacoepidemiol Drug Saf; 2006 Mar; 15(3):161-6. PubMed ID: 16170830
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Requirements for a successful implementation of drug interaction information systems in general practice: results of a questionnaire survey in Germany.
    Bergk V; Gasse C; Schnell R; Haefeli WE
    Eur J Clin Pharmacol; 2004 Oct; 60(8):595-602. PubMed ID: 15351924
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Issues of decision support in institutional pharmacy systems.
    Mackowiak LR; Hayward SL
    Pharm Pract Manag Q; 1998 Apr; 18(1):35-45. PubMed ID: 10177541
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Evaluation of IV compatibility microcomputer software programs.
    Poirier TI; Giudici RA
    Hosp Pharm; 1991 Dec; 26(12):1037-40. PubMed ID: 10114827
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Monitoring drug interactions: whose role is it?
    Giaquinta D
    Manag Care Interface; 2000 Sep; 13(9):69-70. PubMed ID: 11142964
    [No Abstract]   [Full Text] [Related]  

  • 51. Potential utility of data-mining algorithms for early detection of potentially fatal/disabling adverse drug reactions: a retrospective evaluation.
    Hauben M; Reich L
    J Clin Pharmacol; 2005 Apr; 45(4):378-84. PubMed ID: 15778418
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Evaluation of patient counseling microcomputer software programs.
    Poirier TI; Giudici RA
    Hosp Pharm; 1992 May; 27(5):408, 411-5. PubMed ID: 10118329
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Using computer databases to predict and avoid drug-drug interactions in the cancer patient requiring psychotropics.
    Strain JJ; Caliendo G; Himelein C
    Psychooncology; 1998; 7(4):321-32. PubMed ID: 9741071
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [A revolutionary idea: employ five adverse event managers, then clinicians will be happy!].
    Madsen F
    Ugeskr Laeger; 2012 Nov; 174(46):2881. PubMed ID: 23320259
    [No Abstract]   [Full Text] [Related]  

  • 55. Quality assessment of spontaneous triggered adverse event reports received by the Food and Drug Administration.
    Brajovic S; Piazza-Hepp T; Swartz L; Dal Pan G
    Pharmacoepidemiol Drug Saf; 2012 Jun; 21(6):565-70; discussion 571-2. PubMed ID: 22359404
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Reliability of the assessment of preventable adverse drug events in daily clinical practice.
    van Doormaal JE; Mol PG; van den Bemt PM; Zaal RJ; Egberts AC; Kosterink JG; Haaijer-Ruskamp FM
    Pharmacoepidemiol Drug Saf; 2008 Jul; 17(7):645-54. PubMed ID: 18338767
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Food and drug interactions in critically ill adults.
    Harrington L; Gonzales C
    Crit Care Nurs Clin North Am; 2004 Dec; 16(4):501-8. PubMed ID: 15571938
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Vaccinovigilance in Europe--need for timeliness, standardization and resources.
    Lankinen KS; Pastila S; Kilpi T; Nohynek H; Mäkelä PH; Olin P
    Bull World Health Organ; 2004 Nov; 82(11):828-35. PubMed ID: 15640918
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Evaluation of drug information resources for drug-ethanol and drug-tobacco interactions.
    Beckett RD; Stump CD; Dyer MA
    J Med Libr Assoc; 2019 Jan; 107(1):62-71. PubMed ID: 30598650
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Comprehensive evaluation of drug interaction screening programs: discrepancies and concordances].
    Somogyi-Végh A; Nyaka B; Vida RG; Lovász A; Botz L
    Orv Hetil; 2015 May; 156(18):720-30. PubMed ID: 26042779
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.